IRIS Accounts Production v26.1.10.61 05272633 director 1.4.25 31.3.26 31.3.26 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 05272633 2025-03-31 05272633 2026-03-31 05272633 2025-04-01 2026-03-31 05272633 2024-03-31 05272633 2024-04-01 2025-03-31 05272633 2025-03-31 05272633 ns15:EnglandWales 2025-04-01 2026-03-31 05272633 ns14:PoundSterling 2025-04-01 2026-03-31 05272633 ns10:Director1 2025-04-01 2026-03-31 05272633 ns10:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 05272633 ns10:SmallEntities 2025-04-01 2026-03-31 05272633 ns10:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 05272633 ns10:SmallCompaniesRegimeForDirectorsReport 2025-04-01 2026-03-31 05272633 ns10:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 05272633 ns10:FullAccounts 2025-04-01 2026-03-31 05272633 ns10:OrdinaryShareClass2 2025-04-01 2026-03-31 05272633 ns10:OrdinaryShareClass3 2025-04-01 2026-03-31 05272633 ns10:CompanySecretary1 2025-04-01 2026-03-31 05272633 ns10:RegisteredOffice 2025-04-01 2026-03-31 05272633 ns5:CurrentFinancialInstruments 2026-03-31 05272633 ns5:CurrentFinancialInstruments 2025-03-31 05272633 ns5:Non-currentFinancialInstruments 2026-03-31 05272633 ns5:Non-currentFinancialInstruments 2025-03-31 05272633 ns5:ShareCapital 2026-03-31 05272633 ns5:ShareCapital 2025-03-31 05272633 ns5:RetainedEarningsAccumulatedLosses 2026-03-31 05272633 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 05272633 ns5:LandBuildings 2025-03-31 05272633 ns5:LongLeaseholdAssets ns5:LandBuildings 2025-03-31 05272633 ns5:PlantMachinery 2025-03-31 05272633 ns5:MotorVehicles 2025-03-31 05272633 ns5:LandBuildings 2025-04-01 2026-03-31 05272633 ns5:LongLeaseholdAssets ns5:LandBuildings 2025-04-01 2026-03-31 05272633 ns5:PlantMachinery 2025-04-01 2026-03-31 05272633 ns5:MotorVehicles 2025-04-01 2026-03-31 05272633 ns5:LandBuildings 2026-03-31 05272633 ns5:LongLeaseholdAssets ns5:LandBuildings 2026-03-31 05272633 ns5:PlantMachinery 2026-03-31 05272633 ns5:MotorVehicles 2026-03-31 05272633 ns5:LandBuildings 2025-03-31 05272633 ns5:LongLeaseholdAssets ns5:LandBuildings 2025-03-31 05272633 ns5:PlantMachinery 2025-03-31 05272633 ns5:MotorVehicles 2025-03-31 05272633 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2026-03-31 05272633 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31 05272633 ns10:OrdinaryShareClass2 2026-03-31 05272633 ns10:OrdinaryShareClass3 2026-03-31

REGISTERED NUMBER: 05272633 (England and Wales)

| Financial Statements |

| for the Year Ended 31 March 2026 |

| for |

| Northstar Lipids (UK) Ltd |

| Northstar Lipids (UK) Ltd (Registered number: 05272633) |

Contents of the Financial Statements

for the Year Ended 31 March 2026

Page |

| Company Information | 1 |

| Chartered Accountants' Report | 2 |

| Balance Sheet | 3 |

| Notes to the Financial Statements | 4 |

| Northstar Lipids (UK) Ltd |

Company Information

for the Year Ended 31 March 2026

| DIRECTOR: | C J Houghton

| SECRETARY: | K L Houghton

| REGISTERED OFFICE: | Unit 1a Stirlin Court

| Saxilby Enterprise Park

| Skellingthorpe Road

| Saxilby

| Lincolnshire

| LN1 2LR

| REGISTERED NUMBER: | 05272633 (England and Wales)

| ACCOUNTANTS: | Wright Vigar Limited

| Chartered Accountants & Business Advisers

| 15 Newland

| Lincoln

| Lincolnshire

| LN1 1XG

Chartered Accountants' Report to the Director

on the Unaudited Financial Statements of

Northstar Lipids (UK) Ltd

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Northstar Lipids (UK) Ltd for the year ended 31 March 2026 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Northstar Lipids (UK) Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Northstar Lipids (UK) Ltd and state those matters that we have agreed to state to the director of Northstar Lipids (UK) Ltd in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Northstar Lipids (UK) Ltd and its director for our work or for this report.

It is your duty to ensure that Northstar Lipids (UK) Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Northstar Lipids (UK) Ltd. You consider that Northstar Lipids (UK) Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Northstar Lipids (UK) Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Wright Vigar Limited

Chartered Accountants & Business Advisers

15 Newland

Lincoln

Lincolnshire

LN1 1XG

6 July 2026

| Northstar Lipids (UK) Ltd (Registered number: 05272633) |

Balance Sheet

31 March 2026

| 2026 | 2025 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 280,863 |  | 204,534 |  |

CURRENT ASSETS

Stocks | 1,202,041 |  | 1,447,016 |  |

Debtors | 5 | 315,085 |  | 330,143 |  |

Cash at bank | 283,201 |  | 150,263 |  |

1,800,327 |  | 1,927,422 |  |

CREDITORS

Amounts falling due within one year | 6 | 290,894 |  | 441,685 |  |

NET CURRENT ASSETS | 1,509,433 |  | 1,485,737 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 1,790,296 |  | 1,690,271 |  |

CREDITORS

Amounts falling due after more than one year | 7 | (149,944 | ) | (68,668 | ) |

PROVISIONS FOR LIABILITIES | (37,592 | ) | (27,392 | ) |

NET ASSETS | 1,602,760 |  | 1,594,211 |  |

CAPITAL AND RESERVES

Called up share capital | 9 | 100 |  | 100 |  |

Retained earnings | 1,602,660 |  | 1,594,111 |  |

SHAREHOLDERS' FUNDS | 1,602,760 |  | 1,594,211 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 6 July 2026 and were signed by:

C J Houghton - Director

| Northstar Lipids (UK) Ltd (Registered number: 05272633) |

Notes to the Financial Statements

for the Year Ended 31 March 2026

1. | STATUTORY INFORMATION

| Northstar Lipids (UK) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Factored revenue is recorded gross of factoring charges.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful

| life.

| Land |  | - Not depreciated |  |

| Leasehold improvement |  | - 20% on reducing balance |  |

| Plant and machinery |  | - 20% on cost |  |

| Motor vehicles |  | - 20% on reducing balance |  |

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Financial instruments

| A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provision of the instrument.

| Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

| Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

| For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

| Any reversals of impairment are recognised in the profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been would the impairment not previously not been recognised.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Northstar Lipids (UK) Ltd (Registered number: 05272633) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2026

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Foreign currencies

| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 3 (2025 - 3 ) .

4. | TANGIBLE FIXED ASSETS

| Land and |  | Leasehold |  | Plant and |  | Motor |

| Buildings |  | improvements |  | machinery |  | vehicles |  | Totals

£ | £ | £ | £ | £ |

| COST

| At 1 April 2025 | 9,192 |  | 5,821 |  | 55,945 |  | 240,524 |  | 311,482 |  |

| Additions | - |  | 2,733 |  | 5,503 |  | 279,257 |  | 287,493 |  |

| Disposals | - |  | - |  | - |  | (240,524 | ) | (240,524 | ) |

| At 31 March 2026 | 9,192 |  | 8,554 |  | 61,448 |  | 279,257 |  | 358,451 |  |

| DEPRECIATION

| At 1 April 2025 | - |  | 5,142 |  | 50,555 |  | 51,251 |  | 106,948 |  |

| Charge for year | - |  | 452 |  | 2,543 |  | 18,896 |  | 21,891 |  |

| Eliminated on disposal | - |  | - |  | - |  | (51,251 | ) | (51,251 | ) |

| At 31 March 2026 | - |  | 5,594 |  | 53,098 |  | 18,896 |  | 77,588 |  |

| NET BOOK VALUE

| At 31 March 2026 | 9,192 |  | 2,960 |  | 8,350 |  | 260,361 |  | 280,863 |  |

| At 31 March 2025 | 9,192 |  | 679 |  | 5,390 |  | 189,273 |  | 204,534 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

£ | £ |

| Trade debtors | 288,115 |  | 137,607 |  |

| Amounts recoverable on contracts | - |  | 170,139 |  |

| Other debtors | 26,970 |  | 22,397 |  |

315,085 |  | 330,143 |  |

| Northstar Lipids (UK) Ltd (Registered number: 05272633) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2026

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

£ | £ |

| Hire purchase contracts | 972 |  | 4,919 |  |

| Trade creditors | 216,811 |  | 300,977 |  |

| Taxation and social security | 56,755 |  | 59,835 |  |

| Other creditors | 16,356 |  | 75,954 |  |

290,894 |  | 441,685 |  |

7. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

2026 | 2025 |

£ | £ |

| Hire purchase contracts | 149,944 |  | 68,668 |  |

8. | SECURED DEBTS

| The following secured debts are included within creditors:

2026 | 2025 |

£ | £ |

| Factoring creditor | - |  | 175,365 |  |

| These are secured against factored debts.

9. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2026 | 2025 |

| value: | £ | £ |

| 49 | Ordinary A | £1 | 49 |  | 49 |  |

| 51 | Ordinary B | £1 | 51 |  | 51 |  |

100 |  | 100 |  |